Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals

Immunologic Basis of Cardiovascular Disease in HIV-Infected Adults

(2012) Priscilla Y. Hsue et al.   JOURNAL OF INFECTIOUS DISEASES

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders

(2011) S. Piconi et al.   BLOOD

Effect of Highly Active Antiretroviral Therapy on Homocysteine Plasma Concentrations in HIV-1–Infected Patients

(2010) Erika Coria-Ramirez et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Immune and Inflammatory Mechanisms of Atherosclerosis

(2009) Elena Galkina et al.   Annual Review of Immunology

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

(2008)   AIDS

Human immunodeficiency virus per se exerts atherogenic effects

(2008) Ugo Oliviero et al.   ATHEROSCLEROSIS

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

(2008)   LANCET

HIV infection and high density lipoprotein metabolism

(2007) Honor Rose et al.   ATHEROSCLEROSIS

Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

(2007) Peter W. Hunt et al.   JOURNAL OF INFECTIOUS DISEASES